These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2568825)

  • 21. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence.
    Kane JM
    J Clin Psychiatry; 2004; 65 Suppl 9():16-20. PubMed ID: 15189107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tardive dyskinesia in psychiatric outpatients: a study of prevalence and association with demographic, clinical, and drug history variables.
    Mukherjee S; Rosen AM; Cardenas C; Varia V; Olarte S
    Arch Gen Psychiatry; 1982 Apr; 39(4):466-9. PubMed ID: 6121547
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tardive dyskinesia and other clinical consequences of neuroleptic treatment in children and adolescents.
    Gualtieri CT; Quade D; Hicks RE; Mayo JP; Schroeder SR
    Am J Psychiatry; 1984 Jan; 141(1):20-3. PubMed ID: 6140865
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Study of the prevalence of tardive dyskinesia among psychiatric inpatients].
    Zhang LD
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1988 Aug; 21(4):232-5, 255-6. PubMed ID: 2906854
    [No Abstract]   [Full Text] [Related]  

  • 25. Prevalence of tardive dyskinesia in private psychiatric inpatients.
    Arisco JP; Holden LD
    Tex Med; 1989 Jan; 85(1):25-8. PubMed ID: 2564217
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tardive dyskinesia in elderly psychiatric patients: a 5-year study.
    Yassa R; Nastase C; Dupont D; Thibeau M
    Am J Psychiatry; 1992 Sep; 149(9):1206-11. PubMed ID: 1354413
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes is not a risk factor for tardive dyskinesia: a retrospective observational study.
    Raja M; Azzoni A
    Hum Psychopharmacol; 2002 Jan; 17(1):61-3. PubMed ID: 12404708
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tardive dyskinesia and neuroleptic-induced parkinsonism in Japan.
    Binder RL; Kazamatsuri H; Nishimura T; McNiel DE
    Am J Psychiatry; 1987 Nov; 144(11):1494-6. PubMed ID: 2890308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vulnerability to tardive dyskinesia.
    Wolf ME; DeWolfe AS; Ryan JJ; Lips O; Mosnaim AD
    J Clin Psychiatry; 1985 Sep; 46(9):367-8. PubMed ID: 2863257
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tardive dyskinesia in psychiatric patients treated with neuroleptics.
    Perris C; Dimitrijevic P; Jacobsson L; Paulsson P; Rapp W; Fröberg H
    Br J Psychiatry; 1979 Dec; 135():509-14. PubMed ID: 43756
    [No Abstract]   [Full Text] [Related]  

  • 31. [Tardive dyskinesia].
    Sabbatini F; Gentile S; De Mattei M; Pinessi L; Rainero I
    Minerva Med; 1985 Apr; 76(16):797-802. PubMed ID: 2860619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia rates with atypical antipsychotics in older adults.
    Jeste DV
    J Clin Psychiatry; 2004; 65 Suppl 9():21-4. PubMed ID: 15189108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective study of tardive dyskinesia in the elderly: rates and risk factors.
    Woerner MG; Alvir JM; Saltz BL; Lieberman JA; Kane JM
    Am J Psychiatry; 1998 Nov; 155(11):1521-8. PubMed ID: 9812112
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tardive dyskinesia and new antipsychotics.
    Correll CU; Schenk EM
    Curr Opin Psychiatry; 2008 Mar; 21(2):151-6. PubMed ID: 18332662
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Diabetes and development of tardive dyskinesia.
    Woerner MG; Saltz BL; Kane JM; Lieberman JA; Alvir JM
    Am J Psychiatry; 1993 Jun; 150(6):966-8. PubMed ID: 8098587
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tardive dyskinesia in an outpatient population: prevalence and predisposing factors.
    Yassa R; Ananth J; Cordozo S; Ally J
    Can J Psychiatry; 1983 Aug; 28(5):391-4. PubMed ID: 6138143
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous and tardive dyskinesias: clinical and laboratory studies.
    Casey DE
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):42-7. PubMed ID: 2858480
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Tardive dyskinesia (review of the literature)].
    Lerner VE
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(2):124-32. PubMed ID: 2897750
    [No Abstract]   [Full Text] [Related]  

  • 40. Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.
    Morgenstern H; Glazer WM
    Arch Gen Psychiatry; 1993 Sep; 50(9):723-33. PubMed ID: 8102845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.